Jane Street’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.7M | Buy |
37,600
+22,400
| +147% | +$6.6M | ﹤0.01% | 2758 |
|
|
2026
Q1 | $4.51M | Buy |
15,200
+3,500
| +30% | +$1.13M | ﹤0.01% | 3667 |
|
|
2025
Q4 | $3.55M | Sell |
11,700
-10,600
| -48% | -$3.47M | ﹤0.01% | 3763 |
|
|
2025
Q3 | $7.6M | Buy |
22,300
+2,900
| +15% | +$881K | ﹤0.01% | 2796 |
|
|
2025
Q2 | $4.7M | Buy |
19,400
+12,200
| +169% | +$2.99M | ﹤0.01% | 3086 |
|
|
2025
Q1 | $1.96M | Sell |
7,200
-1,300
| -15% | -$304K | ﹤0.01% | 4382 |
|
|
2024
Q4 | $1.57M | Buy |
8,500
+1,800
| +27% | +$368K | ﹤0.01% | 4550 |
|
|
2024
Q3 | $1.5M | Sell |
6,700
-17,100
| -72% | -$3.08M | ﹤0.01% | 5044 |
|
|
2024
Q2 | $3.4M | Buy |
23,800
+12,000
| +102% | +$1.85M | ﹤0.01% | 3598 |
|
|
2024
Q1 | $1.85M | Buy |
11,800
+2,800
| +31% | +$451K | ﹤0.01% | 4277 |
|
|
2023
Q4 | $1.62M | Buy |
9,000
+100
| +1% | +$18.1K | ﹤0.01% | 4697 |
|
|
2023
Q3 | $1.6M | Sell |
8,900
-200
| -2% | -$39.6K | ﹤0.01% | 4422 |
|
|
2023
Q2 | $1.62M | Buy |
9,100
+2,100
| +30% | +$484K | ﹤0.01% | 4478 |
|
|
2023
Q1 | $1.51M | Sell |
7,000
-5,600
| -44% | -$1.34M | ﹤0.01% | 4296 |
|
|
2022
Q4 | $2.77M | Sell |
12,600
-6,000
| -32% | -$1.1M | ﹤0.01% | 3348 |
|
|
2022
Q3 | $2.51M | Buy |
18,600
+11,800
| +174% | +$2.03M | ﹤0.01% | 3791 |
|
|
2022
Q2 | $1.1M | Sell |
6,800
-27,700
| -80% | -$4.33M | ﹤0.01% | 5315 |
|
|
2022
Q1 | $6.51M | Buy |
34,500
+27,800
| +415% | +$5.91M | ﹤0.01% | 2603 |
|
|
2021
Q4 | $1.81M | Sell |
6,700
-2,500
| -27% | -$844K | ﹤0.01% | 4670 |
|
|
2021
Q3 | $3.34M | Buy |
9,200
+8,300
| +922% | +$2.71M | ﹤0.01% | 3458 |
|
|
2021
Q2 | $309K | Sell |
900
-9,500
| -91% | -$3.15M | ﹤0.01% | 8094 |
|
|
2021
Q1 | $3.62M | Sell |
10,400
-800
| -7% | -$265K | ﹤0.01% | 2908 |
|
|
2020
Q4 | $2.89M | Buy |
11,200
+7,900
| +239% | +$2.18M | ﹤0.01% | 2868 |
|
|
2020
Q3 | $945K | Sell |
3,300
-2,700
| -45% | -$635K | ﹤0.01% | 4185 |
|
|
2020
Q2 | $1.13M | Buy |
+6,000
| New | +$977K | ﹤0.01% | 3884 |
|
|
2020
Q1 | – | Sell |
-1,500
| Closed | -$249K | – | 6121 |
|
|
2019
Q4 | $249K | Buy |
+1,500
| New | +$249K | ﹤0.01% | 4506 |
|
|
2019
Q1 | – | Sell |
-2,200
| Closed | -$309K | – | 5761 |
|
|
2018
Q4 | $309K | Buy |
+2,200
| New | +$292K | ﹤0.01% | 4031 |
|
|
2018
Q3 | – | Sell |
-4,500
| Closed | -$692K | – | 5825 |
|
|
2018
Q2 | $692K | Sell |
4,500
-31,000
| -87% | -$5.53M | ﹤0.01% | 3221 |
|
|
2018
Q1 | $5.96M | Buy |
+35,500
| New | +$4.81M | 0.02% | 848 |
|
Other funds holding ONC
BBA
Jane Street's ONC Position: Q2 2026 in Review
Jane Street reduced its BeOne Medicines Ltd (ONC) stake by 88% in Q2 2026, selling an estimated $19.6M and leaving 9,442 shares worth $2.69M. The position accounts for ﹤0.01% of the portfolio, ranked #4665.
Jane Street first reported a position in ONC in Q3 2017 and has held it in 26 quarters since. The position peaked at $24.4M in Q1 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.
- Jane Street held 9,442 shares of BeOne Medicines Ltd worth $2.69M as of Q2 2026.
- Jane Street sold 66,511 BeOne Medicines Ltd shares in Q2 2026, an estimated $19.6M.
- BeOne Medicines Ltd made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #4665 holding.
- Jane Street first reported a position in BeOne Medicines Ltd in Q3 2017 and has held it in 26 quarters since.
- Jane Street's BeOne Medicines Ltd position peaked at $24.4M in Q1 2025.
- 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.